Pharmafile Logo

Webinar: Understanding the Patient Journey in China 2015

January 6, 2016 | Chinese Healthcare, Patient journey 

Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great change. 

Most recently there are concerns that the devaluation in China’s currency has impacted significantly on the local healthcare demand and that the much publicised healthcare reforms that were due to take effect this year have stalled in the implementation. 

Now more than ever, the researcher needs to ensure that they have a full understanding of how these developments will impact the market.

Register now for the latest in our China webinar series where, utilising local knowledge and detailed case studies, we will examine the current Chinese healthcare market, discuss the likely impact of the Government’s healthcare reforms on the patient journey and consider the possible implication for market researchers.

Our Emerging Markets experts Marc Yates and Rachel Howard will also be considering the impact of China’s more recent financial challenges including the lack of growth within the private sector.

Gain answers to your key questions:

  • Gain a deeper understanding of the changing patient journey in China
  • Identify the opportunities and challenges associated with the healthcare reforms 
  • Learn how to ensure that your market research in China continues to answer the business objectives

To view the webinar please visit: bit.ly/1O05iUJ

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Guide

UX research

Article: Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:...

Case study

Using qualitative conjoint to assess willingness-to-pay

Consumer health specialist joins Research Partnership Inc

Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.

Article: What’s next? How behavioural science can support pharma’s future

Dan Coffin, Director explains why now is an opportune time for pharma marketers to embrace behavioural science. Read his latest article for PME Magazine.https://bit.ly/31ef6rh

Video: UX/ Experience design research

Director and UX expert Liza Pliss discusses Research Partnership's approach to user experience research and shares an example of a project where using design thinking led to an agile approach...

White paper: The impact of COVID-19 on chronic disease management

Therapy Watch, Research Partnership's syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management. In this white paper, Research Partnership share some of the insights and...

Article: Pricing a coronavirus vaccine

Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...

News: Living with Ulcerative Colitis and Crohn’s Disease

Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports...

Interactive infographic

Living With: The journey from the patient’s perspective